Tadros, Audree B.
Plitas, George
Funding for this research was provided by:
National Cancer Institute
Article History
Received: 20 November 2020
Accepted: 22 November 2020
First Online: 5 January 2021
Disclosures
: George Plitas serves on the advisory boards of Merck and Tizona, has provided uncompensated services to Rubius Therapeutics and Takeda, and holds intellectual property rights in and has received research funding from Takeda. None of these relationships are related to the content of this study in any way. All other authors declare no financial or other interests.